RANI
NASDAQ · Pharmaceuticals
Rani Therapeutics Holdings-A
$0.88
-0.05 (-5.18%)
Open$0.93
Previous Close$0.93
Day High$0.94
Day Low$0.88
52W High$3.87
52W Low$0.39
Volume—
Avg Volume550.6K
Market Cap115.24M
P/E Ratio—
EPS$-0.59
SectorPharmaceuticals
Analyst Ratings
Strong Buy
10 analysts
Price Target
+4,103.0% upside
Current
$0.88
$0.88
Target
$37.15
$37.15
$30.65
$37.15 avg
$44.71
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 3.22M | 3.82M | 51.04M |
| Net Income | -58,500,982 | -62,412,142 | 8.38M |
| Profit Margin | -1,817.1% | -1,726.2% | 16.4% |
| EBITDA | -74,876,563 | -84,320,453 | 12.88M |
| Free Cash Flow | — | — | 6.14M |
| Rev Growth | -15.6% | -15.6% | +13.5% |
| Debt/Equity | — | — | 0.99 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |